U.S. Life Sciences Stock News

NasdaqGS:OLPX
NasdaqGS:OLPXPersonal Products

Olaplex (OLPX) Q1 Loss Per Share Rekindles Debate Around Turnaround Narratives

Olaplex Holdings (OLPX) opened Q1 2026 with revenue of US$99.4 million and a basic EPS loss of US$0.01, while trailing 12 month figures show revenue of US$425.4 million and a basic EPS loss of US$0.02, keeping the company in loss making territory. Over recent quarters, revenue has moved between US$96.98 million and US$114.6 million with EPS swinging from a profit of US$0.02 in Q3 2025 to losses in several periods, highlighting how sensitive margins remain as the business works through its...
NYSE:FMC
NYSE:FMCChemicals

FMC Governance Overhaul Reshapes Shareholder Access As Performance Pressures Mount

FMC Corporation (NYSE:FMC) shareholders approved amendments to the company’s Certificate of Incorporation and By Laws at the recent Annual Meeting. The changes introduce updated procedural requirements for director nominations and shareholder business proposals. These governance revisions adjust how investors can formally bring matters before the board and at future meetings. FMC’s governance update comes at a time when the stock has faced heavy pressure, with shares at $13.11 and down...
NYSE:SVV
NYSE:SVVMultiline Retail

Is It Time To Reassess Savers Value Village (SVV) After Its Share Price Slide

If you are asking whether Savers Value Village at US$7.54 is starting to look like value, the recent share price performance gives you a clear starting point for that question. The stock has fallen 8.6% over the past week, is down 6.7% over the past month, has declined 20.2% year to date, and is down 33.3% over the past year. This will naturally make some investors wonder whether the risk profile or return potential has changed. Recent coverage has focused on Savers Value Village as a listed...
NYSE:BRO
NYSE:BROInsurance

Is Brown & Brown (BRO) Starting To Look Interesting After A 49.6% One-Year Rally?

If you are wondering whether Brown & Brown is starting to look interesting at its current share price, it helps to step back and ask what you are really paying for in this insurance broker's future cash flows. The stock closed at US$55.35, with returns declining about 4% over the last week, 15% over the last month, 28.7% year to date and 49.6% over the past year. This will naturally raise questions about whether recent price moves reflect changing expectations or create a potential...
NYSE:MH
NYSE:MHConsumer Services

McGraw Hill Data Breach Adds Pressure To Discounted Share Price

McGraw Hill (NYSE:MH) has reported a major data breach alongside an extortion threat targeting its systems and sensitive information. The incident has coincided with a broad selloff across education and training stocks, putting added pressure on the company. Investors are focusing on potential fallout for customer trust, regulatory scrutiny and the company’s operational resilience. The data breach and extortion threat come at a time when McGraw Hill’s share price is already under pressure,...
NasdaqGS:TMC
NasdaqGS:TMCMetals and Mining

TMC The Metals Moves Toward Commercial Seafloor Production With Allseas Deal

TMC the metals (NasdaqGS:TMC) has signed a commercial agreement with Allseas to develop, commission and operate an offshore polymetallic nodule collection system. The system will operate in the Clarion Clipperton Zone and targets a production capacity of 3 million wet tonnes per year. Commissioning of what is expected to be the first large scale nodule recovery system is scheduled to begin in late 2027. TMC the metals is moving from a focus on permitting to building commercial...
NYSE:ENOV
NYSE:ENOVMedical Equipment

Is There Now An Opportunity In Enovis (ENOV) After Multi Year Share Price Slump

For investors wondering whether Enovis stock is starting to look like value or just looks cheap for a reason, this article walks through the key numbers so you can judge the price for yourself. After a recent 6.2% gain over the past week and a 1.5% rise over the past month, the stock still sits lower for the year to date, with a decline of 6.5%, and is down 32.2% over the past year, 56.7% over three years, and 67.3% over five years. Recent coverage has focused on how Enovis fits within the...
NasdaqGS:UTHR
NasdaqGS:UTHRBiotechs

United Therapeutics Phase 3 Lung Data Could Reshape Pulmonary Franchise Outlook

United Therapeutics (NasdaqGS:UTHR) plans to present new phase 3 clinical data for Tyvaso (inhaled treprostinil for idiopathic pulmonary fibrosis) and ralinepag (for pulmonary arterial hypertension) at the upcoming American Thoracic Society International Conference. The company will also share additional research across multiple lung diseases, highlighting a broad set of respiratory-focused findings at the meeting. United Therapeutics focuses on therapies for serious pulmonary and...
NasdaqGM:AGNT
NasdaqGM:AGNTReal Estate

AGNT Rebrands eXp With NextHome Acquisition And Multi Model Upside

eXp World Holdings, now trading under the ticker NasdaqGM:AGNT, has acquired franchise based brokerage NextHome. The company is shifting to a multi model real estate platform that offers both cloud brokerage and franchise options for agents and brokers. The new structure brings multiple brands under one global umbrella, with the AGNT ticker reflecting the broader platform focus. For real estate investors, NasdaqGM:AGNT now represents more than a pure cloud brokerage business. The...
NYSE:LXU
NYSE:LXUChemicals

What LSB Industries (LXU)'s Profit Rebound and Expansion Plans Mean For Shareholders

In late April 2026, LSB Industries, Inc. reported first-quarter sales of US$169.49 million and net income of US$19.69 million, reversing a loss a year earlier. Alongside this earnings improvement, management highlighted active review of debottlenecking projects and potential acquisitions or partnerships to expand fertilizer and industrial production capacity and gain scale. With earnings swinging to profit and management evaluating capacity-expanding investments, we’ll now examine how this...
NasdaqGS:MNST
NasdaqGS:MNSTBeverage

Three High ROE Stocks With Quietly Powerful Balance Sheets

Markets are wrestling with higher inflation, rising bond yields and volatile energy prices, so quality balance sheets matter more than ever. When borrowing costs and policy expectations shift frequently, companies with strong return on equity, resilient past performance and solid finances can give you cleaner exposure to long term growth stories, without relying on heavy leverage or speculative turnarounds. This article focuses on a curated screener that looks exactly for that mix of quality...
NYSE:AGBK
NYSE:AGBKBanks

Is AGI (AGBK) Offering A Rare Opportunity After A 34.8% Year To Date Slide?

Wondering whether AGI at around US$7.01 is a bargain or a value trap? This article walks through the key valuation clues that can help you frame that question. Over the last week the stock gained 2.9%, while over the past month it fell 1.3% and year to date it is down 34.8%. This naturally raises questions about how the market is currently pricing its prospects and risks. Recent coverage has focused on AGI's position in the US banking sector and how its share price has reacted to shifts in...
NasdaqGM:RDNT
NasdaqGM:RDNTHealthcare

RadNet (RDNT) Q1 Loss Widens Again And Tests Bullish AI Margin Narrative

RadNet Q1 2026 earnings: revenue expands while margins stay under pressure RadNet (RDNT) opened 2026 with Q1 revenue of US$575.6 million and a basic EPS loss of US$0.43, as the stock trades around US$58.19. The company has seen revenue move from US$471.4 million in Q1 2025 to US$575.6 million in Q1 2026, while quarterly EPS has shifted from a loss of US$0.51 to a loss of US$0.43 over the same period. This sets up a results season where investors are watching how quickly revenue scale can...
NYSE:ONON
NYSE:ONONLuxury

Lazard And 2 Stocks That May Be Trading Below Their Estimated Value

Over the last 7 days, the United States market has risen by 2.2%, contributing to a significant 31% increase over the past year, with earnings forecasted to grow by 17% annually. In such a robust environment, identifying stocks that may be trading below their estimated value can offer investors potential opportunities for growth and diversification.
NasdaqGS:OPK
NasdaqGS:OPKHealthcare

Spotlight On Promising Penny Stocks For May 2026

Over the last 7 days, the United States market has risen by 2.2%, and over the past year, it has increased by 31%, with earnings forecasted to grow annually by 17%. In light of these conditions, investors may find value in smaller or newer companies that offer growth potential at lower price points. Penny stocks, though an outdated term, still represent a viable investment area for those seeking opportunities in companies with strong financial health and long-term potential.
NasdaqGS:MCBS
NasdaqGS:MCBSBanks

US Market's 3 Undiscovered Gems with Promising Potential

Over the last 7 days, the United States market has risen by 2.2%, contributing to a notable 31% increase over the past year, with earnings expected to grow by 17% annually in the coming years. In this thriving environment, identifying stocks with strong fundamentals and growth potential can be key to uncovering hidden opportunities within the market's landscape.